Velcera, Inc. Signs Definitive Agreement to be Acquired by Perrigo Company for $160 Million in Cash

  Velcera, Inc. Signs Definitive Agreement to be Acquired by Perrigo Company
  for $160 Million in Cash

Business Wire

YARDLEY, Pa. -- February 1, 2013

Velcera, a privately-held, developer, manufacturer and marketer of OTC
companion animal healthcare products, announced today that it has signed a
definitive agreement to be acquired by the Perrigo Company (Nasdaq: PRGO;TASE)
for $160 million in cash. The acquisition is expected to close during calendar
year 2013 pending the satisfaction of closing conditions, including regulatory
approvals. Subject to conditions at the time of closing and based upon current
company assumptions, shareholders of Velcera common stock will be entitled to
receive approximately $0.40 per share upon consummation of the transaction
before allowance for an escrow holdback.

Dennis Steadman, President and CEO, Velcera said, “The extraordinary synergies
between Velcera and Perrigo means that even more pet owners can receive
best-in-class pet health products, including PetArmor®, the brand they know
and trust to deliver veterinarian quality protection for their pets.”

About Velcera, Inc.

Velcera through its FidoPharm subsidiary is a leading companion pet health
product company committed to providing consumers with best-in-class companion
pet health products that contain the same active ingredients as branded
veterinary products, but at a significantly lower cost. FidoPharm products,
including PetArmor^® flea & tick preventive – which contains the same active
ingredient as Frontline® Top Spot® – are available at major retailer’s
nationwide, offering consumers the benefits of convenience and cost savings to
ensure the highest quality care for their pets. FidoPharm is a subsidiary of
Velcera located in Yardley, Pa.


Velcera, Inc.
Ron Schmid, 610-659-3985
Press spacebar to pause and continue. Press esc to stop.